198 related articles for article (PubMed ID: 22845649)
1. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
King AB; Clark D; Wolfe GS
Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
Kuroda A; Yasuda T; Takahara M; Sakamoto F; Kasami R; Miyashita K; Yoshida S; Kondo E; Aihara K; Endo I; Matsuoka TA; Kaneto H; Matsumoto T; Shimomura I; Matsuhisa M
Diabetes Technol Ther; 2012 Nov; 14(11):1077-80. PubMed ID: 23101953
[TBL] [Abstract][Full Text] [Related]
3. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.
King AB
Endocr Pract; 2010; 16(3):428-32. PubMed ID: 20061290
[TBL] [Abstract][Full Text] [Related]
4. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
5. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(3):382-6. PubMed ID: 22440988
[TBL] [Abstract][Full Text] [Related]
6. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
King AB
Endocr Pract; 2009 Apr; 15(3):229-33. PubMed ID: 19364691
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing.
King AB; Armstrong DU
J Diabetes Sci Technol; 2007 Jan; 1(1):42-6. PubMed ID: 19888378
[TBL] [Abstract][Full Text] [Related]
8. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.
Edelman SV; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Chen X; Frias JP
Diabetes Technol Ther; 2010 Aug; 12(8):627-33. PubMed ID: 20615104
[TBL] [Abstract][Full Text] [Related]
9. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.
Frias JP; Bode BW; Bailey TS; Kipnes MS; Brunelle R; Edelman SV
J Diabetes Sci Technol; 2011 Jul; 5(4):887-93. PubMed ID: 21880230
[TBL] [Abstract][Full Text] [Related]
10. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
[TBL] [Abstract][Full Text] [Related]
11. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
Zisser HC; Bevier WC; Jovanovic L
Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
[TBL] [Abstract][Full Text] [Related]
12. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
13. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
Levitt DL; Spanakis EK; Ryan KA; Silver KD
Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
[TBL] [Abstract][Full Text] [Related]
14. Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy.
Bondia J; Dassau E; Zisser H; Calm R; Vehí J; Jovanovič L; Doyle FJ
J Diabetes Sci Technol; 2009 Jan; 3(1):89-97. PubMed ID: 20046653
[TBL] [Abstract][Full Text] [Related]
15. No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring.
King AB
J Diabetes Sci Technol; 2010 Jan; 4(1):151-4. PubMed ID: 20167179
[TBL] [Abstract][Full Text] [Related]
16. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
[TBL] [Abstract][Full Text] [Related]
18. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
[TBL] [Abstract][Full Text] [Related]
19. Neonatal diabetes and insulin pump therapy.
Beardsall K; Pesterfield CL; Acerini CL
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
[TBL] [Abstract][Full Text] [Related]
20. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
